Chile vs Peru: Avoidable mortality
Avoidable mortality over time
- Chile
- Peru
How they compare
Peru currently reports 61,983 Deaths against 36,190 Deaths in Chile, a difference of 25,793 Deaths.
That makes Peru's figure about 1.7 times Chile's.
Across all 23 years both countries report, Peru has been ahead every year.
Chile ranks 19th and Peru ranks 16th of 36 countries.
Peru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32,674 Deaths | 39,466 Deaths | 6,793 Deaths | Peru |
| 2010s | 33,829 Deaths | 42,511 Deaths | 8,683 Deaths | Peru |
| 2020s | 44,043 Deaths | 103,149 Deaths | 59,106 Deaths | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher avoidable mortality, Chile or Peru?
- Peru, at 61,983 Deaths against 36,190 Deaths in Chile as of 2022.
- What is the difference in avoidable mortality between Chile and Peru?
- 25,793 Deaths, with Peru ahead.
- How many years of comparable data are there for Chile and Peru?
- 23 years are reported by both, from 2000 to 2022.
- How do Chile and Peru rank globally for avoidable mortality?
- Chile ranks 19th and Peru ranks 16th of 36 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Avoidable mortality. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents data on preventable, treatable and avoidable (preventable + treatable) causes of mortality. Preventable and treatable causes of mortality are defined as follows: - Preventable mortality: Causes of death that can be mainly avoided through effective public health and primary prevention interventions (i.e. before the onset of diseases/injuries, to reduce incidence). - Treatable (or amenable) mortality: Causes of death that can be mainly avoided through timely and effective healthcare interventions, including secondary prevention such as screening, and treatment (i.e. after the onset of diseases, to reduce case-fatality). Both indicators refer to premature mortality (under age 75). Please refer to the Sources and Methods for detailed country-specific information.